FIELD: organic chemistry, medicine, endocrinology, pharmacy.
SUBSTANCE: invention relates to a derivative of 5-thio-β-D-glucopyranoside of the formula (i): wherein Y represents -O- or -NH-; R2, R2 or R3 represents hydrogen atom, acyl or phenyl-(C1-C4)-alkyl; R4 represents hydrogen atom, acyl, alkoxycarbonyl or phenyl-(C1-C4)-alkyl; Ar represents phenyl or naphthyl substituted with -X-A1, and phenyl can be substituted additionally with 1-3 similar or different substitutes chosen from halogen atom, hydroxyl and others; X represents -(CH2)n-, -CO(CH2)n-, -CH(OH)(CH2)n-, -O-(CH2)n-, -CONH(CH2)n- wherein n means a whole number from 0 to 3, -COCH=CH-, -S- or -NH-; A1 represents phenyl, naphthyl or heteroaryl chosen from benzofuranyl group, pyridyl group, pyrazolyl group and thiazolyl group wherein three latter groups can be substituted additionally with alkyl, and phenyl group can be substituted with 1-4 similar or different substitutes chosen from halogen atom, hydroxyl and others; or its pharmaceutically acceptable salt or its hydrate. Derivatives of the formula (i) possess inhibitory effect with respect to SGLT2 activity. Also, invention relates to a pharmaceutical composition representing prophylactic or therapeutic agent used in diabetes mellitus, diseases or complications associated with diabetes mellitus. Also, invention relates to a derivative of 5-thio-β-D-glucopyranoside of the formula (III): wherein R21, R22, R23 and R24 means hydrogen atom or acyl; R25 means amino group, alkanoyl, carboxyl or alkoxycarbonyl; R26 means hydrogen atom or hydroxy group; R27 means hydrogen atom or alkyl; or to its pharmaceutically acceptable salt or hydrate. Derivatives of the formula (III) are intermediate compound used in synthesis of compounds of the formula (I): wherein Y means -O-; each among R1, R2 or R3 represents hydrogen atom, acyl or phenyl-(C1-C4)-alkyl; R4 represents hydrogen atom, acyl, alkoxycarbonyl or phenyl-(C1-C4)-alkyl; one radical among R5, R6, R7, R8 and R9 represents -X-A1 (wherein X and A1 have values given above), and others represent hydrogen atom, halogen atom and others.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
17 cl, 4 sch, 1 tbl, 30 ex
Title | Year | Author | Number |
---|---|---|---|
1-THIO-D-GLUCITOL DERIVATIVES | 2006 |
|
RU2387649C2 |
NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
SPIROKETAL DERIVATIVES AND USE THEREOF AS MEDICINAL AGENT AGAINST DIABETES | 2006 |
|
RU2416617C2 |
C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
PESTICIDE COMPOSITIONS AND METHODS RELATING THERETO | 2012 |
|
RU2596946C2 |
TRICYCLIC COMPOUNDS OF BENZOPYRAN AS ANTIARRHYTHMIC AGENTS | 2005 |
|
RU2380370C2 |
BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF FOR INHIBITING NOREPINEPHRINE, DOPAMINE AND SEROTONIN REUPTAKE | 2005 |
|
RU2388751C2 |
PESTICIDE COMPOSITIONS AND METHODS RELATING THERETO | 2012 |
|
RU2605537C2 |
DERIVATIVES OF SUBSTITUTED TRIAZOLDIAMINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS PREPARING | 2001 |
|
RU2274639C2 |
Authors
Dates
2008-04-20—Published
2003-08-08—Filed